Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03462030 · ClinicalTrials.gov registry record · Phase 2
Baked Milk Oral Immunotherapy for Cow's Milk Allergy
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 41
- Enrollment target
NCT03462030: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT03462030 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03462030, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether baked milk oral immunotherapy is safe in the treatment of cow's milk allergy.
Interventions
- DRUG Baked non-fat cow's milk powder
- DRUG Placebo: Tapioca Powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2018-03-15 |
| Est. Completion | 2024-02-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03462030
The ClinicalTrials.gov registry entry for NCT03462030 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Baked non-fat cow's milk powder is the first listed.
NCT03462030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03462030 about?
NCT03462030 is a clinical study titled "Baked Milk Oral Immunotherapy for Cow's Milk Allergy". The purpose of this study is to determine whether baked milk oral immunotherapy is safe in the treatment of cow's milk allergy.
What is the current status of trial NCT03462030?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 41 participants. The study started on 2018-03-15. Estimated completion is 2024-02-19.
What interventions are being tested in trial NCT03462030?
The interventions under investigation include: Baked non-fat cow's milk powder (DRUG), Placebo: Tapioca Powder (DRUG).
Who is sponsoring clinical trial NCT03462030?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.